#NewAseBioAlly | “AseBio provides us with the opportunity to be part of an ecosystem facin... 13/03/2025 Healthcare Access to innovation Meet Fieldfisher, our new Ally. We spoke with Gemma Colomer, Principal Associte, and Arian Gallardo, Associate. Other/sector
Biotechnology Advances in the development of key therapies for kidney diseases 13/03/2025 Healthcare Innovative drugs Personalized medicine Advanced therapies By 2040, chronic kidney disease (CKD) is projected to become the fifth leading cause of years of life lost, emphasizing... AseBio
Bionet introduces the new version of the F1 Bioreactor — your ultimate solution for versat... 06/03/2025 Healthcare Access to innovation Innovative drugs All bioprocessing requirements in one, every detail of every application meticulously addressed. Partners - Bionet Ingeniería
Oryzon announces publication of study on Phelan-McDermid Syndrome (PMS) patients, a form o... 06/03/2025 Healthcare Access to innovation Personalized medicine Advanced therapies La revista Frontiers in Psychiatry publica un estudio que proporciona escalas clínicas y umbrales para la selección de... Partners - Oryzon Genomics
Public Affairs: The Roadmap That Will Shape the Future of Biotechnology 06/03/2025 Healthcare Talento Corporate The Balearic Biotechnology and Biomedical Cluster (BIOIB) is leading a pioneering study in Spain on the impact of public... Partners - BIOIB
CONNECTA Therapeutics announces positive results from Phase I study of neurodevelopmental ... 06/03/2025 Healthcare Access to innovation Innovative drugs Advanced therapies CONNECTA Therapeutics has achieved positive results in the Phase I clinical trial of CTH120, an investigational drug... Partners - CONNECTA THERAPEUTICS
BCN HEALTH publishes a study evaluating the incidence and cost of atopic dermatitis in Spa... 04/03/2025 Healthcare Partners - BCN Health
Oryzon defines Phase III Trial endpoints for Agitation and Aggression in BPD with input f... 03/03/2025 Healthcare Expertos líderes en psiquiatría en EE.UU. se unen al Comité Asesor Clínico (CAC) de Oryzon para avanzar en el desarrollo... Partners - Oryzon Genomics
Accelerating Innovation from Discovery to Development 03/03/2025 Healthcare Access to innovation Innovative drugs Personalized medicine Advanced therapies Pharmaron accelerates drug discovery by transforming scientific breakthroughs into therapies, using advanced... Partners
ORYZON reports financial results and corporate update for quarter ended December 31, 2024 03/03/2025 Healthcare Innovative drugs Se han realizado inversiones en I+D por importe de 8,3 M€, de las cuales 7,6 M€ corresponden a desarrollo y 0,7 M€ a... Partners - Oryzon Genomics
